|
1
|
PREDNISONE (250MG)/53-03-2
|
LABORATORIO DE PRODUCTOS ETICOS COMERCIAL E INDUSTRIAL SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-10-03
|
CHINA
|
0.09 Kgs
|
0.09 0
|
|
2
|
FLUOXETINE RELATED COMPOUND A (15MG)(N-METHYL-3-PHENYL-3-[3-(TRIFLUOROMETHYL)PHENOXY]PROPAN-1-AMINE HYDROCHLORIDE)
|
LABORATORIO DE PRODUCTOS ETICOS COMERCIAL E INDUSTRIAL SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-10-03
|
INDIA
|
0.05 Kgs
|
0.05 0
|
|
3
|
FLUOXETINE HYDROCHLORIDE (200MG)/56296-78-7
|
LABORATORIO DE PRODUCTOS ETICOS COMERCIAL E INDUSTRIAL SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-10-03
|
ITALY
|
0.05 Kgs
|
0.05 0
|
|
4
|
DISSOLUTION PERFORMANCE VERIFICATION STANDARD-PREDNISONE (30 TABLETS)/53-03-2 (PREDNISONE)
|
LABORATORIO DE PRODUCTOS ETICOS COMERCIAL E INDUSTRIAL SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-10-03
|
SPAIN
|
0.09 Kgs
|
0.09 0
|
|
5
|
LIVEO MEDICAL ANTIFOAM C EMULSION (SIMETICONA)
|
COMFAR SA EMISORA DE CAPITAL ABIERTO
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-09-16
|
UNITED STATES
|
449 Kgs
|
396 0
|
|
6
|
LIDOCAINE (250 MG)
|
SCAVONE HERMANOS SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-08-14
|
INDIA
|
0.03 Kgs
|
0.03 0
|
|
7
|
ATORVASTATIN RELATED COMPOUND D (10 MG) (EPOXIDE IMPURITY, 3-(4-FLUOROBENZOYL)-2-ISOBUTYRYL-3-PHENYL
|
SCAVONE HERMANOS SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-08-14
|
INDIA
|
0.03 Kgs
|
0.03 0
|
|
8
|
ATORVASTATIN RELATED COMPOUND C (20 MG) (CALCIUM (3R,5R)-7-[2,3-BIS(4-FLUOROPHENYL)-5-ISOPROPYL-4-(P
|
SCAVONE HERMANOS SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-08-14
|
INDIA
|
0.03 Kgs
|
0.03 0
|
|
9
|
ATORVASTATIN RELATED COMPOUND B (20 MG) (CALCIUM (3S,5R)-7-[2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-
|
SCAVONE HERMANOS SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-08-14
|
INDIA
|
0.03 Kgs
|
0.03 0
|
|
10
|
ATORVASTATIN RELATED COMPOUND A (20 MG) (DESFLUORO IMPURITY, OR (3R,5R)-7-[3-(PHENYLCARBAMOYL)-2-ISO
|
SCAVONE HERMANOS SA
|
U.S. PHARMACOPEIAL CONVENTION
|
2025-08-14
|
INDIA
|
0.03 Kgs
|
0.03 0
|